Cargando…

Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment

Detalles Bibliográficos
Autores principales:	Delavar, Arash, Boutros, Catherine, Barnea, Dana, Schaffer, Wendy L., Tonorezos, Emily S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389675/ https://www.ncbi.nlm.nih.gov/pubmed/35986386 http://dx.doi.org/10.1186/s40959-022-00141-2

Ejemplares similares

Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
por: Delavar, Arash, et al.
Publicado: (2022)

Hearing Loss in Adult Survivors of Childhood Cancer Treated with Radiotherapy
por: Khan, Amber, et al.
Publicado: (2018)

Benign and Malignant Findings on Chest CT Among Adult Survivors of Childhood and Young Adult Cancer with a History of Chest Radiotherapy
por: Barnea, Dana, et al.
Publicado: (2023)

Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines
por: Franco, Vivian I., et al.
Publicado: (2011)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
por: Long, Treya M., et al.
Publicado: (2019)

Clinical Guidelines for the Care of Childhood Cancer Survivors
por: Tonorezos, Emily S., et al.
Publicado: (2014)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
por: Li, Vivian Wing-yi, et al.
Publicado: (2018)

Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
por: Singh, Purnima, et al.
Publicado: (2023)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Cardiotoxicity After Anthracycline Treatment in Survivors of Adult Cancers: Monitoring by USCOM, Echocardiography and Serum Biomarkers
por: Pastore, Alessandro, et al.
Publicado: (2013)

Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study
por: Leerink, Jan M., et al.
Publicado: (2022)

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
por: Sadurska, Elżbieta
Publicado: (2015)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
por: Desai, Lajja, et al.
Publicado: (2019)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

Cardiac Events in Childhood Cancer Survivors Treated with Anthracyclines: The Value of Previous Myocardial Strain Measurement
por: Pourier, Milanthy, et al.
Publicado: (2022)

Local arterial stiffness measured by ultrafast ultrasound imaging in childhood cancer survivors treated with anthracyclines
por: Rasouli, Rahna, et al.
Publicado: (2023)

2166 Development of a statin risk communication tool for use in cancer survivors: A pilot
por: Raghunathan, Nirupa J., et al.
Publicado: (2018)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
por: Mladosievicova, Beata, et al.
Publicado: (2012)

Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study
por: Baker, Laurence H., et al.
Publicado: (2020)

Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
por: Beaudry, Rhys I., et al.
Publicado: (2022)

Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?
por: Fradley, Michael G., et al.
Publicado: (2021)

Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet?
por: Wong-Siegel, Jeannette R., et al.
Publicado: (2023)

T066: Treatment and sex-specific exposure-based risk-stratification for care of survivors of childhood Hodgkin Lymphoma: A report from the Childhood Cancer Survivor Study
por: Dinan, Michaela, et al.
Publicado: (2022)

Radiation Sterilization of Anthracycline Antibiotics in Solid State
por: Kaczmarek, A., et al.
Publicado: (2013)

Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors
por: Varghese, Sonu S., et al.
Publicado: (2021)

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009)

Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines
por: Tagawa, Michihito, et al.
Publicado: (2021)

Early Detection of Anthracycline-Induced Cardiotoxicity in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Low Cumulative Dose
por: Salvo, Giovanni Di, et al.
Publicado: (2014)

Left ventricular dyssynchrony in long-term childhood cancer survivors treated with anthracyclines: a retrospective cross-sectional study
por: Pourier, Milanthy S., et al.
Publicado: (2021)

Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
por: Merkx, Remy, et al.
Publicado: (2021)

Using Behavioral Science to Address COVID-19 Vaccine Hesitancy Among Cancer Survivors: Communication Strategies and Research Opportunities
por: Vanderpool, Robin C., et al.
Publicado: (2022)

Author Correction: Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study
por: Hong, Yoo Jin, et al.
Publicado: (2022)

Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation
por: Zafar, Meer R., et al.
Publicado: (2023)

Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
por: Armenian, Saro H., et al.
Publicado: (2012)

Evaluation of Cardiotoxic Effects of Anthracyclines by Tissue Doppler Imaging in Survivors of Childhood Cancer
por: Caliskan, Munise, et al.
Publicado: (2021)

Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study
por: Alkofide, Hadeel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_076g3ahuh9l3uqsnc2qj568o0s